Table 6.

Risk Ratios for Initiating Statins Within 90 Days of a Coronary Heart Disease Event Associated Excluding Patients Who Had No Medication Fills, Who Had Cardiology Care, and Who Filled Nonstatin Lipid‐Lowering Therapies During the 365‐Day Baseline Period

	Categories of CHD Event
	AMI, Primary Discharge Diagnosis (n=3254)	AMI, Secondary Discharge Diagnosis (n=1361)	PCI (n=608)	CABG (n=218)
Statin initiation, %	60.8	31.1	65.4	69.0
Risk ratio (95% CI) for initiating statins
Unadjusted	1 (ref)	0.51 (0.46 to 0.57)	1.12 (1.01 to 1.25)	1.24 (1.06 to 1.45)
Model 1	1 (ref)	0.53 (0.48 to 0.59)	1.03 (0.92 to 1.14)	1.09 (0.93 to 1.28)
Model 2	1 (ref)	0.59 (0.53 to 0.66)	1.02 (0.90 to 1.15)	1.13 (0.94 to 1.34)

Model 1 is adjusted for age, race, sex, and calendar year and accounted for clustering by hospital. Model 2 is adjusted for age, race, sex, calendar year, socioeconomic status, comorbidities (history of hyperlipidemia, history of diabetes, history of stroke, history of renal disease, history of depression, Charlson comorbidity index, all‐cause hospitalization), skilled nursing facility stay, nursing home residence, most recent cardiologist care, number of medications, filled nonstatin lipid‐lowering drugs, duration of hospitalization for the index CHD event, and hospitalization during the 90 days following discharge and accounted for clustering by hospital. AMI indicates acute myocardial infarction; CABG, coronary artery bypass grafting; CHD, coronary heart disease; PCI, percutaneous coronary intervention.